Patrick was born in Paisley, Scotland in 1979. He spent his formative years on the beautiful island of Bute on the west coast of Scotland. He moved to Glasgow in 1997 where he completed his B.Sc. (hons) and Ph.D. in Chemistry with Profs. Andrew Benniston and Robert Peacock at the University of Glasgow. Patrick crossed the Atlantic in 2005 to pursue Post-doctoral studies at Yale University under the mentorship of Prof. Andrew Hamilton. There he developed a love for medicinal chemistry and chemical biology.

 

In 2007, Patrick accepted an Assistant Professorship position at the University of Toronto Mississauga Chemistry Department. In 10 years Patrick is now a full Professor, a Canada Research chair in Medicinal Chemistry, and the Director of the Centre for Medicinal Chemistry. He has published ~ 100 research papers, won 19 research awards including Canada’s Top 40 under 40, founded three pharmaceutical companies with over $22M in funding, and developed a dynamic and diverse medicinal chemistry program targeting protein-protein interactions, a most challenging of targets. Patrick’s team develop inhibitors of proteins that drive the most rare and lethal of human cancers, including glioblastoma, acute myeloid leukemia, multiple myeloma, and refractory medulloblastoma. These inhibitors are in advanced preclinical trials and en route to Phase I clinical trial.

PATRICK GUNNING

Career
  • 2016 - Present Full Professor, University of Toronto Mississauga, Department of Chemical & Physical Sciences

  • 2013 - Present - Canada Research Chair in Medicinal Chemistry, Tier II, University of Toronto Mississauga, Department of Chemical & Physical Sciences and Department of Chemistry (Graduate Department)

  • 2012 - 2016 - Associate Professor, University of Toronto Mississauga, Department of Chemical & Physical Sciences and Department of Chemistry (Graduate Department)

  • 2007 - 2012 - Assistant Professor, University of Toronto Mississauga, Department of Chemical & Physical Sciences and Department of Chemistry (Graduate Department)

  • 2005 - 2007 - Post-doctoral Research Associate, Yale University

  • 2001 - 2004 - Ph.D. University of Glasgow

  • 1997 - 2001 - B.Sc.(hons), University of Glasgow

 

Awards and Honours
  • Royal Bank of Canada RBC Prize for Innovation & Entrepreneurship; 2017

  • Canada's Top 40 Under 40, Caldwell Partners; 2017

  • McLean Award, Connaught Foundation, University of Toronto; 2016

  • Canadian Society for Chemistry Bernard Belleau Award, Canadian Society for Chemistry; 2016

  • McLean Award, Connaught Foundation, University of Toronto; 2015

  • Honorary Member of the Golden Key International Honour Society, York University Chapter (UK); 2015

  • Rose Winer Levin Lectureship, Dana-Farber Cancer Institute, Harvard Medical School (USA); 2015

  • Natural Sciences Engineering Research Council (NSERC) Accelerator Award (Canada); 2015

  • Canada Research Chair in Medicinal Chemistry, Tier II (Canada); 2015

  • Baird of Bute Scottish Innovation Award ­ Baird of Bute Society (UK); 2013

  • University of Toronto Inventors of the Year ­University of Toronto Innovations and Partnership Office (Canada); 2013

  • CSC Ichikizaki Fund for Young Chemists Award ­Canadian Society for Chemistry (Canada); 2013

  • Toronto Star's Top 10 people to watch in 2013; 2013

  • Royal Society for Chemistry’s MedChemComm Emerging Investigator Lectureship Award (UK); 2012

  • CSC Ichikizaki Fund for Young Chemists Award ­Canadian Society for Chemistry (Canada); 2012

  • CSC Ichikizaki Fund for Young Chemists Award ­Canadian Society for Chemistry (Canada); 2011

  • Dean's Research Excellence Award at University of Toronto Mississauga ­UTM (Canada); 2011

  • Boehringer Ingelheim Young Investigator Award ­Boehringer Ingelheim (Canada); 2010

  • University of Glasgow Young Alumnus of the Year, University of Glasgow (UK); 2010

  • Early Researcher Award, Ministry of Research and Innovation, Province of Ontario; 2010

  • Awarded the David Rae Memorial Award for Innovative Research in the field of Leukemia and Lymphoma Research by the Leukemia and Lymphoma Society of Canada; 2008

  • Royal Society Chemistry, Dalton Transactions National Meeting, University of Edinburgh, Presentation Award (1st); 2004

 

 

 

UNIVERSITY OF TORONTO MISSISSAUGA

GUNNING GROUP © 2019

CONTACT US

  • White LinkedIn Icon
  • White Twitter Icon